EyeGate Pharmaceuticals I...

35.45
-0.02 (-0.07%)
At close: Mar 31, 2025, 2:29 PM
35.54
0.25%
After-hours: Mar 31, 2025, 04:00 PM EDT

EyeGate Pharmaceuticals Ratios Statement

Year FY24 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
PE Ratio 17.54 -1.94 -4.49 -1.53 -1.15 -1.08 -2.27 -27.98 -9.23 -0.23
PEG Ratio n/a -0.14 0.09 0.02 0.03 -0.04 -0.01 0.42 0.09 n/a
PS Ratio 8.46 1.3K 11.87 9.99 37.44 21.52 n/a n/a n/a n/a
PB Ratio 5.26 2.24 4.81 1.85 -7.92 -43.71 3.12 -1.06 -0.8 -0.03
P/FCF Ratio 15.84 -2.1 -3.91 -1.49 -2.35 -1.71 -4.27 -52.21 -12.11 -0.26
P/OCF Ratio 15.83 -2.14 -3.91 -1.52 -2.36 -1.71 -4.27 -52.21 -12.11 -0.26
OCF/S Ratio 0.53 -606.78 -3.04 -6.56 -15.87 -12.57 n/a n/a n/a n/a
Debt / Equity Ratio 0.00 0.05 0.01 0.00 -0.01 -0.09 n/a -0.07 -0.05 -0.00
Quick Ratio 4.94 1.02 3.06 2.19 0.57 0.57 2.76 0.04 0.22 2.75
Current Ratio 4.94 1.02 3.06 2.19 0.57 0.57 2.76 0.04 0.22 2.75
Asset Turnover 0.44 0.00 0.27 0.12 0.03 0.07 n/a n/a n/a n/a
Interest Coverage -122.89 -1.96K -21.87K -10.43K -11.98K -48.53K -3.45 -5.57 -5.07 n/a
Return on Equity (ROE) 0.30 -1.16 -1.07 -1.21 6.86 40.51 -1.38 0.04 0.09 0.15
Return on Assets (ROA) 0.21 -0.53 -0.7 -0.76 -0.92 -1.37 -0.88 -1.26 -5.6 -2.58
Return on Capital (ROIC) 0.09 -0.61 -0.82 -1.04 27.57 -5.51 -1.1 0.68 1.65 -3.67
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 0.11% 100.00% 100.00% 100.00% 100.00% n/a n/a n/a n/a
Net Profit Margin 48.22% -67.1K% -264.21% -654.24% -3.24K% -1.99K% n/a n/a n/a n/a
Pretax Profit Margin 35.33% -67K% -260.66% -649.03% -3.57K% -1.99K% n/a n/a n/a n/a
Operating Profit Margin 16.45% -68.1K% -264.67% -656.25% -3.57K% -1.99K% n/a n/a n/a n/a
FCF Margin 53.39% -61.79K% -303.57% -672.58% -1.6K% -1.26K% n/a n/a n/a n/a
EBITDA Margin n/a -66.69K% -252.68% -646.64% -3.57K% -1.99K% n/a n/a n/a n/a